asa guidelines for glp 1 drugs A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia asa glp 1 guidelines 2025
Description
On the other hand, FDA-approved medications like Wegovy and Zepbound offer a proven path to weight loss with significantly lower risks

Int Rev Cell Mol Biology

Which region is expected to show the highest growth rate for GLP-1 Receptor Agonists

Methods GLP-1 agonists included in the analysis were approved for treatment of obesity (Saxenda, Wegovy, Zepbound) and corresponding formulations that may potentially be used off-label for treatment of obesity (Mounjaro, Ozempic, Rybelsus, Victoza)

Translationally, this perspective supports structured evaluation of micronutrient status aimed at maintaining enzymatic capacity rather than indiscriminate supplementation
